ThursdayOct 26, 2017 12:02 pm

HempNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at the Global Skincare Market

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products. An article discussing this reads: “Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market that's projected to reach $135 billion by 2021 (http://cnw.fm/ud2WJ). SKVI also sees a worldwide dermatology market of $80 billion, plus a $30 billion worldwide over-the-counter (OTC) market (http://cnw.fm/noE7Y). It has already completed the development of 40 products, received numerous technology and product patents and is now ready to monetize its investment. In the U.S. alone, skincare is projected to reach $10.7 billion…

Continue Reading

WednesdayOct 25, 2017 12:56 pm

HempNewsBreaks – ChineseInvestors.com (CIIX) Targets CBD Health Products Market through New Website, Mobile App

ChineseInvestors.com (OTCQB: CIIX) continues to rapidly grow in 2017, which is primarily attributed to the company’s focus on the cannabidiol (CBD) health products market. An article discussing this reads: “Among the reported highlights is the company’s revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments (http://cnw.fm/uYF8x). CIIX’s business strategy of targeting the emerging cannabidiol (CBD) health products market includes bringing a new website online for its subsidiary ChineseCBDoil.com (http://cnw.fm/7WTcx). This website offers the world’s first 'CBD health products online store in the Chinese language.' At the same time, CIIX launched…

Continue Reading

ThursdayOct 19, 2017 12:24 pm

HempNewsBreaks – Canada’s Cannabis Market Presents Big Potential for Algae Dynamics Corp. (ADYNF)

In Canada, where recreational marijuana is expected to be legalized in 2018 and where registered clients are projected to increase to 715,000 by 2020 and cumulatively purchase 124,443 kg of dried medical marijuana annually, Algae Dynamics Corp. (OTCQB: ADYNF) foresees huge opportunity and greater market share. If the model seen in Colorado’s cannabis market holds true, by 2018 approximately 45 percent of Canada’s cannabis consumers will have switched from dried medical marijuana to cannabis extracts/oil. This is great news for ADYNF, which produces health products and nutraceuticals utilizing cannabis, hemp and algae oils. An article discussing this reads: “(ADYNF) is…

Continue Reading

ThursdayOct 19, 2017 12:24 pm

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Poised to be First to Market in China’s Multibillion-Dollar Skin Care Industry with Line of Cannabidiol-Based Products

ChineseInvestors.com (OTCQB: CIIX) is quickly moving into the multibillion-dollar Chinese skin care industry and is introducing its first line of cannabidiol (CBD) based skin care products. CIIX has already filed a record with the China Food and Drug Administration for this line of hemp-infused skin care products and hopes to launch within the next couple of months. An article discussing this reads: “China is the second-largest consumer of skin care products in the world and generates nearly $30 billion in annual retail sales. Since no other notable manufacturers have entered the cannabis skin care product market in China, CIIX would…

Continue Reading

ThursdayOct 19, 2017 12:24 pm

HempNewsBreaks – Marijuana Company of America (MCOA) Stands Out among Cannabis and Hemp Industry Innovators

Constant growth within the legal marijuana and hemp industries also means increasingly fierce competition in this burgeoning market, which makes it more and more difficult for companies in the cannabis space to stand out from the pack. Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model. An article discussing this reads: “The exponential growth of the legal cannabis market and the hemp-based CBD industry enables Marijuana Company of America to fully develop its vertically integrated business…

Continue Reading

FridayOct 13, 2017 11:16 am

HempNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://nnw.fm/l2NJw). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as 40 percent without neuron damage. An article discussing this reads: “This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment…

Continue Reading

ThursdayOct 12, 2017 2:27 pm

HempNewsBreaks – Why Skinvisible, Inc. (SKVI) is Worth Watching in a $65B Market

Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is an R&D company offering its patented Invisicare® technology, which can be used to revitalize or create new medical or skincare products, thus enabling companies that license Skinvisible’s formulations to sell their own patented products and ward off generic rivals. A high-performance topical and transdermal delivery system, Invisicare enhances the delivery of drugs and other ingredients to and through the skin utilizing Skinvisible’s innovative formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions.  An article discussing this reads: “A prescription dermatology product…

Continue Reading

ThursdayOct 12, 2017 9:30 am

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Frontrunner in the Delivery of Non-Psychoactive Cannabinoids

Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology. This technology is already being applied to the use of non-psychoactive cannabinoids, yielding a high-absorption hemp oil formula that is a source of omega and fatty acids, and patents are pending for tetrahydrocannabinol (THC) and other psychoactive cannabinoids along with nicotine and nonsteroidal anti-inflammatory drugs. An article discussing this reads: “The patent awarded to LXRP for the delivery of all non-psychoactive…

Continue Reading

ThursdayOct 12, 2017 9:30 am

HempNewsBreaks – Why Cannabis Market Investors are Keeping an Eye on EVIO, Inc. (EVIO)

EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, is a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry and provides state-mandated ancillary services required for ensuring the safety and quality of the cannabis supply in the United States. During the past two years, EVIO Labs has performed more than 50,000 tests and has evolved from operating one laboratory in Oregon to having nine labs that span California, Oregon, Colorado, Massachusetts and Florida. An article discussing this reads: “EVIO Labs is driving the cannabis testing industry by providing clients nationwide with…

Continue Reading

WednesdayOct 11, 2017 2:35 pm

HempNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Sharpens Focus on Potentially Game-Changing Sustained Release Cannabinoid Formulation

Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) recently entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of Canntab’s patent-pending oral sustained release cannabinoid formulation. The agreement grants Emblem the exclusive right to Canntab’s patents and expertise in Canada to develop, commercialize, use, sell and offer—but not import or export—the product, which will be sold under the Emblem brand. An article discussing this reads: “For pharmaceutical ingredients that are typically short-acting, like cannabinoids, sustained release formulations enable dosage schedules that are…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722